London, UK—Lipoatrophy

San Francisco, USA—New & Emerging Therapies

Los Angeles, USA—New & Emerging Therapies

   Click Here for more information about ATLIS
 

ONLINE CEs

This activity is intended to enhance knowledge and competence in the contemporary management of ART-related metabolic complications to improve long-term outcomes in HIV-infected patients.

Chairperson: Kathleen Squires, MD
Thomas Jefferson University

On completion of this activity, participants should be able to:

• Identify two major metabolic complications associated with HIV therapy
• Describe the pathogenic mechanisms involved in these complications
• Define strategies to manage metabolic complications of HIV therapy

DIME designates this educational activity for a maximum of 1.25 AMA PRA Category 1 Credit(s) TM. There is no fee for participation in this activity.

Click Here for More Information

This educational activity has been designed to address the considerations involved in choosing an initial regimen for starting a patient on ARV therapy, preventing and managing metabolic changes, increasing adherence, and preventing viral resistance

Activity Chairperson
Paul E. Sax, MD